Inhibrx Biosciences, Inc. operates as an American clinical-stage biotechnology company for biologic therapeutic candidates. The private company is based in DE.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company